Premium
AlloVir Inc (ALVR)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting fi... AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0312 | -6.93025322079 | 0.4502 | 0.48 | 0.4021 | 284936 | 0.45125378 | CS |
| 4 | -0.161 | -27.7586206897 | 0.58 | 0.5996 | 0.4021 | 327246 | 0.50486317 | CS |
| 12 | -0.371 | -46.9620253165 | 0.79 | 1.05 | 0.4021 | 355063 | 0.68402747 | CS |
| 26 | -0.3053 | -42.1510423858 | 0.7243 | 1.05 | 0.4021 | 274053 | 0.71304234 | CS |
| 52 | -1.971 | -82.4686192469 | 2.39 | 2.42 | 0.4021 | 741982 | 0.72442969 | CS |
| 156 | -13.711 | -97.0346779901 | 14.13 | 15.32 | 0.4021 | 687183 | 3.43000211 | CS |
| 260 | -22.401 | -98.1638913234 | 22.82 | 48.96 | 0.4021 | 559775 | 7.36876365 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
